Maravai LifeSciences Holdings, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Maravai LifeSciences Holdings, Inc. (MRVI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$12.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$12.42M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$3.73M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-12-31 was -$35.68M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$25.56M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2025 was -$130.77M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2024 was -$144.85M.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2023 was -$119.03M, a 154.05% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. net income (loss) available to common stockholders, basic for fiscal 2022 was $220.21M, a 20.97% increase from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.42M 10-Q · filed 2026-08-07 | -$16.15M 10-Q · filed 2026-08-07 | -$51.83M derived: sum of 3 quarters · filed 2026-08-07 | -$77.39M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$3.73M 10-Q · filed 2026-05-08 | -$39.41M derived: sum of 2 quarters · filed 2026-05-08 | -$64.97M derived: sum of 3 quarters · filed 2026-05-08 | -$104.56M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$35.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$61.24M derived: sum of 2 quarters · filed 2026-02-26 | -$100.83M derived: sum of 3 quarters · filed 2026-08-07 | -$130.77M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$25.56M 10-Q · filed 2025-11-07 | -$65.15M derived: sum of 2 quarters · filed 2026-08-07 | -$95.09M 10-Q · filed 2025-11-07 | -$121.00M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | -$39.59M 10-Q · filed 2026-08-07 | -$69.54M 10-Q · filed 2026-08-07 | -$95.44M derived: sum of 3 quarters · filed 2026-08-07 | -$192.51M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$29.95M 10-Q · filed 2026-05-08 | -$55.85M derived: sum of 2 quarters · filed 2026-05-08 | -$152.92M derived: sum of 3 quarters · filed 2026-05-08 | -$162.71M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$25.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$122.98M derived: sum of 2 quarters · filed 2026-02-26 | -$132.77M derived: sum of 3 quarters · filed 2026-02-26 | -$144.85M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$97.07M 10-Q · filed 2025-11-07 | -$99.04M 10-Q · filed 2024-11-12 | -$106.86M derived: sum of 2 quarters · filed 2025-11-07 | -$118.94M 10-Q · filed 2025-11-07 | -$118.70M 10-Q · filed 2024-11-12 | -$224.90M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$9.79M 10-Q · filed 2025-08-11 | -$7.58M 10-Q · filed 2024-08-08 | -$21.87M 10-Q · filed 2025-08-11 | -$19.66M 10-Q · filed 2024-08-08 | -$127.83M derived: sum of 3 quarters · filed 2026-02-26 | -$134.29M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$12.08M 10-Q · filed 2025-05-12 | -$118.04M derived: sum of 2 quarters · filed 2026-02-26 | -$124.50M derived: sum of 3 quarters · filed 2026-02-26 | -$131.04M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | -$105.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$112.42M derived: sum of 2 quarters · filed 2026-02-26 | -$118.96M derived: sum of 3 quarters · filed 2026-02-26 | -$119.03M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$6.46M 10-Q · filed 2024-11-12 | -$13.00M derived: sum of 2 quarters · filed 2024-11-12 | -$13.07M 10-Q · filed 2024-11-12 | $24.56M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | -$6.54M 10-Q · filed 2024-08-08 | -$6.61M 10-Q · filed 2024-08-08 | $31.03M derived: sum of 3 quarters · filed 2025-03-18 | $75.50M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$67.00K 10-Q · filed 2024-05-09 | $37.57M derived: sum of 2 quarters · filed 2025-03-18 | $82.04M derived: sum of 3 quarters · filed 2025-03-18 | $153.28M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $37.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $82.10M derived: sum of 2 quarters · filed 2025-03-18 | $153.34M derived: sum of 3 quarters · filed 2025-03-18 | $220.21M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $44.47M 10-Q · filed 2023-11-08 | $115.71M derived: sum of 2 quarters · filed 2023-11-08 | $182.57M 10-Q · filed 2023-11-08 | $238.40M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $71.24M 10-Q · filed 2023-08-08 | $138.10M 10-Q · filed 2023-08-08 | $193.93M derived: sum of 3 quarters · filed 2024-02-29 | $247.89M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $66.86M 10-Q · filed 2023-05-09 | $122.69M derived: sum of 2 quarters · filed 2024-02-29 | $176.65M derived: sum of 3 quarters · filed 2024-02-29 | $225.80M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $55.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $109.79M derived: sum of 2 quarters · filed 2024-02-29 | $158.94M derived: sum of 3 quarters · filed 2024-02-29 | $182.04M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $53.96M 10-Q · filed 2022-11-04 | $54.27M 10-Q · filed 2021-11-15 | $103.11M derived: sum of 2 quarters · filed 2022-11-04 | $126.21M 10-Q · filed 2022-11-04 | $126.60M 10-Q · filed 2021-11-15 | $149.56M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $49.14M 10-Q · filed 2022-08-05 | $49.08M 10-Q · filed 2021-08-11 | $72.25M 10-Q · filed 2022-08-05 | $72.32M 10-Q · filed 2021-08-11 | $95.60M derived: sum of 3 quarters · filed 2023-02-28 | $126.82M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $23.10M 10-Q · filed 2022-05-06 | $23.25M 10-Q · filed 2021-05-12 | $46.46M derived: sum of 2 quarters · filed 2023-02-28 | $77.68M derived: sum of 3 quarters · filed 2023-02-28 | $77.89M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $23.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $54.58M derived: sum of 2 quarters · filed 2023-02-28 | $54.78M derived: sum of 3 quarters · filed 2023-02-28 | $76.89M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $31.22M 10-Q · filed 2021-11-15 | $31.43M derived: sum of 2 quarters · filed 2021-11-15 | $53.53M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $207.00K 10-Q · filed 2021-08-11 | $22.31M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $22.33M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | -$8.49M 10-K · filed 2022-03-01 |